Semaglutide is an injectable medication typically used to treat diabetes. However, it can also be prescribed for weight loss under the brand name Wegovy. Semaglutide is a prescription medication ...

A new study showed that semaglutide may help with alcohol use disorder Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and Reader's Digest.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

The somewhat alarmist commercial -- "obesity is America's deadliest epidemic," intoned the narrator -- touted one of the higher-potential Hims & Hers' offerings, its compounded semaglutide weight ...

Feb. 13, 2025 – For years, some people taking the drug semaglutide to treat diabetes or obesity have reported not only eating less, but drinking less alcohol. The reports have prompted many to ...

Languages: English. The weight-loss and diabetes drug Ozempic, a semaglutide, can lead to people drinking less alcohol, a clinical trial has found. Results showing that people craved and drank ...

A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...

And recently, the Food and Drug Administration announced that semaglutide, the active ingredient in Ozempic and Wegovy (which Novo Nordisk makes), is no longer in shortage. That could undermine ...

Study: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder A Randomized Clinical Trial. Image Credit: simon jhuan/Shutterstock.com A recent JAMA Psychiatry study investigates the ...

Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with ...